NCCN Guidelines as published in JNCCN;

NCCN Guidelines as published in JNCCN;

NCCN Guidelines as published in JNCCN; Bichakjian, et al The new National Comprehensive Cancer Network (NCCN) guidelines have just been published in the Journal of the National Comprehensive Cancer Network (JNCCN), (Bichakjian, et al). They contain a revised version...
The first-ever

The first-ever

The first-ever phase 3 trial in MCC and is a major academic collaboration across several US cancer centers. – Poster presentation on Mon, Jun...
ADAM trial:

ADAM trial:

A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in Merkel cell carcinoma patients with clinically detected lymph node metastases NCT03271372; Shailender Bhatia et al. A poster presentation at the...